Cytokines: Influence on glial cell gene expression and function

Chemical Immunology

Volumn 69, Issue , 1997, Pages 31-75

  Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; NEUROTRANSMITTER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ASTROCYTE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DEMYELINATION; GENE EXPRESSION REGULATION; GLIA CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; MICROGLIA; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW;

EID: 0030663981     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058653     Document Type: Review

References (330)

1. Baker CF, Billingham RF: Immunologically privileged sites. Adv Immunol 1977;25:1-49.
2. Nathanson JA, Chun LLY: Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci USA 1989;86:1684-1688.
3. Shrikant P, Benveniste EN: The central nervous system as an immunocompetent organ: Role of glial cells in antigen presentation. J Immunol 1996;157:1819-1822.
4. Hickey WF, Hsu BL, Kimura H: T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-260.
5. Prineas JW: Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 1979;203:1123-1125.
6. Moench TR, Griffin DE: Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med 1984;159:77-88.
7. Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: Distribution of T-cells, T-cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983;4:201-221.
8. Hauser SL, Bhan AK, Gilles FH, et al: Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes and the Ia antigen. J Neuroimmunol 1983;5:197-205.
9. Prineas JW, Wright RG: Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 1978;38:409-421.
10. Navia BA, Jordan BD, Price RW: The AIDS dementia complex. Ann Neurol 1986;19:517-524.
11. Raine CS: Biology of disease: Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab Invest 1984;50:608-635.
12. Virchow R: Cellular Pathology as Based upon Physiological and Pathological Histology (edited and translated by F Chance). London, Churchill, 1860.
13. Eddleston M, Mucke L: Molecular profile of reactive astrocytes: Implications for their role in neurologic disease. Neuroscience 1993;54:15-36.
14. Bignami A, Eng LF, Dahl D, Uyeda CT: Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 1972;43:429-435.
15. McCall MA, Gregg RG, Behringer RR, et al: Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 1996;93:6361-6366.
16. Pekny M, Levéen P, Pekna M, et al: Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J 1995;14:1590-1598.
17. Norenberg MD: The distribution of glutamine synthetase in the rat central nervous system. J Histochem Cytochem 1979;27:756-762.
18. Norenberg MD, Martinez-Hernandez A: Fine structural localization of glutamine synthetase in astrocytes in rat brain. Brain Res 1979;161:303-310.
19. Sadasivudu B, Rao TL, Murthy CR: Acute metabolic effects of ammonia in mouse brain. Neurochem Res 1977;2:639-645.
20. Ghandour MS, Langley OK, Labourdette G, Vencendon G, Gombos G: Specific and artifactual cellular localization of S-100 protein: An astrocyte marker in rat cerebellum. Dev Neurosci 1981; 4:66-78.
21. Herschman HR, Levine L, de Vellis J: Appearance of a brain-specific antigen (S-100 protein) in the developing rat brain. J Neurochem 1971;18:629-633.
22. Selinfreund RH, Barger SW, Welsh MJ, Van Eldik LJ: Antisense inhibition of glial S100β production results in alterations in cell morphology, cytoskeletal organization, and cell proliferation. J Cell Biol 1990;111:2021-2028.
23. Selinfreund RH, Bager SW, Pledger WJ, Van Eldik LJ: Neurotrophic protein S100β stimulates glial cell proliferation. Proc Natl Acad Sci USA 1991;88:3554-3558.
24. Kojima K, Berger T, Lassmann H, et al: Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 1994;180:817-829.
25. Selmaj K: Pathophysiology of the blood-brain barrier. Springer Semin Immunopathol 1996;18: 57-73.
26. Abbott NJ, Revest PA, Romero IA: Astrocyte-endothelial interaction: Physiology and pathology. Neuropathol Appl Neurobiol 1992;18:424-433.
27. Wolburg H, Risau W: Formation of the blood-brain barrier: in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 763-776.
28. Rubin LL, Hall DE, Porter S, et al: A cell culture model of the blood-brain barrier. J Cell Biol 1991;115:1725-1735.
29. Janzer RC, Raff MC: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987;325:253-257.
30. Hurwitz AA, Berman JW, Rashbaum WK, Lyman WD: Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells. Brain Res 1993;625: 238-243.
31. Isobe I, Watanabe T, Yotsuyanagi T, et al: Astrocytic contributions to blood-brain barrier (BBB) formation by endothelial cells: A possible use of aortic endothelial cell for in vitro BBB model. Neurochem Int 1996;28:523-533.
32. Rakic P: Guidance of neurons migrating to the fetal monkey neocortex. Brain Res 1971;33:471-476.
33. Rakic P: Neuron-glial relationship during granule cell migration in developing cerebellar cortex: A Golgi and electronmicroscopic study in Maccacus rhesus. J Comp Neurol 1971;141:238-312.
34. Schmechel DE, Rakic P: A Golgi study of radial glial cells in developing monkey telencephalon: Morphologenesis and transformation into astrocytes. Anat Embryol 1979;156:115-152.
35. Rakic P: Radial glial cells: Scaffolding for brain construction: in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 746-762.
36. Hatten ME: Riding the glial monorail: A common mechanism for glial guided neuronal migration in different regions of the developing mammalian brain. Trends Neurosci 1990;13:179-184.
37. Choi BH, Lapham LW: Interactions of neurons and astrocytes during growth and development of human fetal brain in vitro. Exp Molec Pathol 1976;24:110-125.
38. Zheng C, Heintz N, Hatten ME: CNS gene encoding astrotactin, which supports neuronal migration along glial fibers. Science 1996;272:417-419.
39. Newman EA: Glial cell regulation of extracellular potassium; in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 717-731.
40. Erecinska M, Silver IA: Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990;35:245-296.
41. Lipton SA, Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622.
42. Martin DL: The role of glia in the activation of neurotransmitters, in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 732-745.
43. Nicholls D, Attwell D: The release and uptake of excitatory amino acids. Trends Pharmacol Sci 1990;11:462-468.
44. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16: 675-686.
45. Mennerick S, Zorumski CF: Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature 1994;368:59-62.
46. Balazs R, Machiyama Y, Hammond BJ, Julian T, Richter D: The operation of the γ-aminobutyrate bypath of the tricarboxylic acid cycle in brain tissue in vitro. Biochem J 1970;116:445-467.
47. Hatten ME, Liem RKH, Shelanski ML, Mason CA: Astroglia in CNS injury. Glia 1991;4:233-243.
48. Benveniste EN: Cytokine production; in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 700-716.
49. Miller R: Oligodendrocyte origins. Trends Neurosci 1996;19:92-96.
50. Norton WT, Cammer W: Isolation and characterization of myelin; in Morrel P (ed): Myelin. New York, Plenum Press, 1984, pp 147-180.
51. Lees MB, Brostoff SW: Proteins of myelin; in Morrel P (ed): Myelin. New York, Plenum Press, 1984, pp 197-217.
52. Raff MC, Mirsky R, Fields KL, et al: Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature 1978;274:813-815.
53. Bloom FE, Battenberg EL, Milner RJ, Sutcliffe JG: Immunocytochemical mapping of 1B236. A brain-specific neuronal polypeptide deduced from the sequence of a cloned mRNA. J Neurosci 1985;5:1781-1802.
54. Ranscht B, Clapshaw PA, Pride J, Noble M, Seifert W: Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 1982;79:2709-2713.
55. Pfeiffer SE, Warrington AE, Bansal R: The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993;3:191-197.
56. Morell P, Norton WT: Myelin. Scient Am 1980;242:88-118.
57. Bunge RP: Glial cells and the central myelin sheath. Physiol Rev 1968;48:197-251.
58. del Rio-Hortega P: Microglia; in Penfield W (ed): Cytology and Cellular Pathology of the Nervous System. New York, Hoeber, 1932, pp 481-584.
59. Hickey WF, Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.
60. Perry VH, Gordon S: Macrophages and microglia in the nervous system. Trends Neurosci 1988; 11:273-277.
61. Gehrmann J, Matsumoto Y, Kreutzberg GW: Microglia: Intrinsic immuneffector cell of the brain. Brain Res Rev 1995;20:269-287.
62. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312-318.
63. Graeber MB, Streit WJ, Kreutzberg GW: Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res 1989;22:103-106.
64. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW: Cytotoxicity of microglia. Glia 1993;7:111-118.
65. Gordon S: The macrophage. BioEssays 1995;17:977-986.
66. Lassmann H, Vass FZK, Hickey WF: Microglial cells are a component of the perivascular glia limitans. J Neurosci Res 1991;28:236-243.
67. Walker DG, Kim SU, McGeer PL: Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 1995;40:478-493.
68. Shrikant P, Weber E, Jilling T, Benveniste EN: ICAM-1 gene expression by glial cells: Differential mechanisms of inhibition by interleukin-10 and interleukin-6. J Immunol 1995;155:1489-1501.
69. Panek RB, Benveniste EN: Class II MHC gene expression in microglia: Regulation by the cytokines IFN-γ, TNF-α and TGF-β. J Immunol 1995;154:2846-2854.
70. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A: Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur J Immunol 1987;17:1271-1278.
71. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH: MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: Induction of Ia antigen expression by γ-interferon. J Neuroimmunol 1987;15:263-278.
72. Williams K, Ulvestad E, Antel JP: B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 1994;24:3031-3037.
73. De Simone R, Giampaolo A, Giometto B, et al: The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 1995;54:175-187.
74. Ulvestad E, Williams K, Bjerkvig R, Tiekotter K, Antel J, Matre R: Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J Leukoc Biol 1994;56:732-740.
75. Korotzer AR, Watt J, Cribbs D, et al: Cultured rat microglia express C1q and receptor for C1q: Implications for amyloid effects on microglia. Exp Neurol 1995;134:214-221.
76. Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW: Biology of adult human microglia in culture: Comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol 1992;51:538-549.
77. Adams CWM: Pathology of multiple sclerosis: Progression of the lesion. Br Med J 1977;33:15-20.
78. Prineas JW: Pathology of the early lesion in multiple sclerosis. Hum Pathol 1975;6:531-554.
79. Giulian D, Lachman LB: Interleukin 1 stimulation of astroglial proliferation after brain injury. Science 1985;228:497-499.
80. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB: Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988;8:2485-2490.
81. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF: Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990;144:129-135.
82. Ranki A, Nyberg M, Ovod V, et al: Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995;9:1001-1008.
83. Tornatore C, Chandra R, Berger JR, Major EO: HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994;44:481-487.
84. Saito Y, Sharer LR, Epstein LG, et al: Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994;44:474-481.
85. Nottet HSLM, Jett M, Flanagan CR, et al: A regulatory role for astrocytes in HIV-1 encephalitis: An overexpression of eicosanoids, platelet-activating factor, and tumor necrosis factor-α by activated HIV-1-infected monocytes is attenuated by primary human astrocytes. J Immunol 1995;154:3567-3581.
86. Nottet HSLM, Gendelman HE: Unraveling the neuroimmune mechanisms for the HIV-1 associated cognitive/motor complex. Immunol Today 1995;16:441-448.
87. Nath A, Power C, Geiger JD: Interactions of the human immunodeficiency virus with astrocytes. Persp Drug Disc Design 1996;5:30-42.
88. Patton HK, Benveniste EN, Benos DJ: Astrocytes and the AIDS dementia complex. J Neuro-AIDS 1996;1:111-131.
89. Raine CS, Scheinberg CC, Waltz JM: Multiple sclerosis: Oligodendrocyte survival and proliferation in an active, established lesion. Lab Invest 1981;45:534-546.
90. Raine CS: Neurons, astrocytes and ependyma; in Davis RL, Robertson DM (eds): Textbook of Neuropathology. Baltimore, Williams & Wilkins, 1985, pp 468-547.
91. Prineas JW, Connell F: Remyelination in multiple sclerosis. Ann Neurol 1979;5:22-31.
92. Raine CS, Moore GRW, Hintzen R, Traugott U: Induction of oligodendrocyte proliferation and remyelination after chronic demyelination: Relevance to multiple sclerosis. Lab Invest 1988;59: 467-476.
93. Agresti C, D'Urso D, Levi G: Reversible inhibitory effects of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 1996;8:1106-1116.
94. Benveniste EN, Kutsunai S, Merrill JE: Immunoregulatory molecules modulate glial cell growth: in Oppenhem JJ (ed): Leukocytes and Host Defense. New York, Liss, 1986, pp 221-226.
95. Saneto RP, Altman A, Knobler R, Johnson HM, de Vellis J: Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci USA 1986;83:9221-9225.
96. Robbins DS, Shirazi Y, Drysdale BE, Lieberman A, Shin HS, Shin ML: Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987;139:2593-2597.
97. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-346.
98. Eilbott DJ, Peress N, Burger H, et al: Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages. Proc Natl Acad Sci USA 1989;86:3337-3341.
99. Koenig S, Gendelman HE, Orenstein TM, et al: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
100. Sharpless NE, O'Brien WA, Verdin E, Kufta CV, Chen ISY, Dubois-Dalcq M: Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J Virol 1992;66:2588-2593.
101. Watkins BA, Dorn HH, Kelly WB, et al: Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science 1990;249:549-553.
102. Peudenier S, Hery C, Montagnier L, Tardieu M: Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1. Ann Neurol 1991;29: 152-161.
103. Ioannidis JPA, Reichlin S, Skolnik PR: Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am J Pathol 1995;147:1200-1206.
104. Lee SC, Hatch WC, Liu W, Brosnan CF, Dickson DW: Productive infection of human fetal microglia in vitro by HIV-1. Ann NY Acad Sci 1993;693:314-316.
105. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD: Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1994;38:365-375.
106. Hofman FM, VonHanwher R, Dinarello C, Mizel S, Hinton D, Merrill JE: Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 1986;136:3239-3245.
107. Winghagen A, Newcombe J, Dangond F, et al: Expression of costimulatory moleculels B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182;1985-1996.
108. Gerritse K, Laman JD, Noelle RJ, et al: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996;93:2499-2504.
109. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993;178:669-674.
110. Benveniste EN: Role of cytokines in multiple sclerosis, autoimmune encephalitis, and other neurological disorders: in Aggarawal B, Puri R (eds): Human Cytokines: Their Role in Research and Therapy. Boston, Blackwell, 1995, pp 195-216.
111. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci 1996;19:331-338.
112. McArthur JC, Hoover DR, Bacellar H, et al: Dementia in AIDS patients: Incidence and risk factors. Neurology 1993;43:2245-2252.
113. Glass JD, Johnson RT: Human immunodeficiency virus and the brain. Ann Rev Neurosci 1996; 19:1-26.
114. Stanley LC, Mrak RE, Woody RC, et al: Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J Neuropathol Exp Neurol 1994;53:231-238.
115. Sheng JG, Mrak RE, Griffin WST: Microglial interleukin-1α expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol Appl Neurobiol 1995;21:290-301.
116. Selmaj K, Raine CS, Cross AH: Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694-700.
117. Aggarwal BB, Natarajan K: Tumor necrosis factors: Development during the last decade. Eur Cytokine Net 1996;7:93-124.
118. Bazzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 1996; 334:1717-1725.
119. Lotz M, Setareh M, von Kempis J, Schwarz H: The nerve growth factor/tumor necrosis factor receptor family. J Leukoc Biol 1996;60:1-7.
120. Hetier E, Ayala J, Bousseau A, Denefle P, Prochiantz A: Amoeboid microglial cells and not astrocytes synthesize TNF-α in swiss mouse brain cell cultures. Eur J Neurosci 1990;2:762-768.
121. Sawada M, Kondo N, Suzumura A, Marunouchi T: Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989;491:394-397.
122. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989;86:6348-6352.
123. Chung IY, Benveniste EN: Tumor necrosis factor-α production by astrocytes: Induction by lipopolysaccharide, IFN-γ and IL-1β. J Immunol 1990;144:2999-3007.
124. Breder CD, Dinarello CA, Saper CB: Interleukin-1 immunoreactive innervation of human hypothalamus. Science 1988;240:321-324.
125. Tchélingérian J-L, Quinonero J, Booss J, Jacque C: Localization of TNFα and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 1993;10:213-224.
126. Grell M, Douni E, Wajant H, et al: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802.
127. de Giovine FS, Duff GW: Interleukin 1: The first interleukin. Immunol Today 1990;11:13-14.
128. Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T: Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 1990;59:783-836.
129. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-1325.
130. Dripps DJ: Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991;266:10331-10336.
131. Kuno K, Matsushima K: The IL-1 receptor signaling pathway. J Leukoc Biol 1994;56:542-547.
132. Colotta F, Re F, Muzio M, et al: Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-475.
133. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 1995;86:1243-1254.
134. Kishimoto T, Taga T, Akira S: Cytokine signal transduction. Cell 1994;76:253-262.
135. Stahl N, Boulton TG, Farruggella T, et al: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components. Science 1994;263:92-95.
136. Zhong Z, Wen Z, Darnell JE Jr: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-98.
137. Akira S, Nishio Y, Inoue M, et al: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994;77:63-71.
138. Billiau A: Interferon-γ: Biology and role in pathogenesis. Adv Immunol 1996:61-130.
139. Rohn WM, Lee Y-J, Benveniste EN: Regulation of class II MHC expression. Crit Rev Immunol 1996;16:311-330.
140. Farrar MA, Schreiber RD: The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993;11:571-611.
141. Greenlund AC, Farrar MA, Viviano BL, Schreiber RD: Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 1994;13: 1591-1600.
142. Darnell JE Jr, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
143. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 1994;15: 127-133.
144. Keiner GS, Kennedy J, Bacon KB, et al: Lymphotactin: A cytokine that represents a new class of chemokine. Science 1994;266:1395-1399.
145. Power CA, Wells TNC: Cloning and characterization of human chemokine receptors. Trends Pharmacol Sci 1996;17:209-213.
146. Doranz BJ, Rucker J, Yi Y, et al: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
147. Alkhatib G, Combadiere C, Broder CC, et al: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
148. Deng H, Liu R, Ellmeier W, et al: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-666.
149. Moore KW, O'Garra A, de Waal Malefyt M, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11:165-190.
150. Miyazono K, Hidenori I, Heldin CH: Transforming growth factor-β: Latent forms, binding proteins and receptors. Growth Factors 1993;8:11-22.
151. Wahl SM: Transforming growth factor-β: The good, the bad, the ugly. J Exp Med 1994;180: 1587-1590.
152. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J: Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
153. Fontana A, Dubs R, Merchant R, Balsiger S, Grob PJ: Glia cell stimulating factor (GSF): A new lymphokine. I. Cellular sources and partial purification of murine GSF, role of cytoskeleton and protein synthesis in its production. J Neuroimmunol 1982;2:55-71.
154. Fontana A, Otz U, DeWeck AL, Grob PJ: Glia cell stimulating factor (GSF): A new lymphokine. 2. Cellular sources and partial purification of human GSF. J Neuroimmunol 1982;2:73-81.
155. Merrill JE, Kutsunai S, Mohlstrom C, Hofman F, Groopman J, Golde DW: Proliferation of astroglia and oligodendroglia in response to human T-cell derived factors. Science 1984;224:1428-1431.
156. Benveniste EN, Merrill JE, Kaufman SE, Golde DW, Gasson JC: Purification and characterization of human T-lymphocyte derived glial growth promoting factor. Proc Natl Acad Sci USA 1985;82: 3930-3934.
157. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E: Production of prostaglandin E and an interleukin-1-like factor by cultured astrocytes and C6 glioma cells. J Immunol 1982;129:2413-2419.
158. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW: Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994;14:846-856.
159. Lachman LB, Brown DC, Dinarello CA: Growth promoting effect of recombinant interleukin-1 and tumor necrosis factor for a human astrocytoma cell line. J Immunol 1987;138:2913-2916.
160. Bethea JR, Gillespie GY, Chung IY, Benveniste EN: Tumor necrosis factor production and receptor expression by a human astroglioma cell line. J Neuroimmunol 1990;30:1-13.
161. Campbell IL, Abraham CR, Masliah E, et al: Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993;90:10061-10065.
162. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G: IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 1995;7:2441-2449.
163. Yong VW, Moumdjian R, Yong FP, et al: γ-Interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991;88:7016-7020.
164. Yong VW, Tejada-Berges T, Goodyer CG, Antel JP, Yong FP: Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia 1992;6:269-280.
165. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H: Transforming growth factor-β1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation. J Cell Biol 1992;117:395-400.
166. Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM: Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J Neuroimmunol 1992; 39:163-174.
167. Hunter KE, Sporn MB, Davies AM: Transforming growth factor-βs inhibit mitogen-stimulated proliferation of astrocytes. Glia 1993;7:203-211.
168. Iwasaki K, Rogers LR, Estes ML, Barna BP: Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-α and/or interferon γ. Neurosurgery 1993;33:489-494.
169. Xiao B-G, Zhang G-X, Ma C-G, Link H: Transforming growth factor-beta1 (TGF β1)-mediated inhibition of glial cell proliferation and down-regulation of intercellular adhesion molecule-1 (ICAM-1) are interrupted by interferon-gamma (IFN-γ). Clin Exp Immunol 1996;103:475-481.
170. Estes ML, Iwasaki K, Jacobs BS, Barna BP: Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation. Am J Pathol 1993;143:337-341.
171. Balasingam V, Yong VW: Attenuation of astroglial reactivity by interleukin-10. J Neurosci 1996; 16:2945-2955.
172. Hurwitz AA, Lyman WD, Guida MP, Calderon TM, Berman JW: Tumor necrosis factor α induces adhesion molecule expression on human fetal astrocytes. J Exp Med 1992;176:1631-1636.
173. Frohman EM, Frohman TC, Dustin ML, et al: The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin, and interleukin-1: Relevance to intracerebral antigen presentation. J Neuroimmunol 1989;23:117-124.
174. Shrikant P, Chung IY, Ballestas M, Benveniste EN: Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes. J Neuroimmunol 1994;51:209-220.
175. Héry C, Sebire G, Peudenier S, Tardieu M: Adhesion to human neurons and astrocytes of monocytes: The role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol 1995; 57:101-109.
176. Rosenman SJ, Shrikant P, Dubb L, Benveniste EN, Ransohoff RM: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 1995;154:1888-1899.
177. Shrikant P, Lee SJ, Kalvakalanu I, Ransohoff RM, Benveniste EN: Stimulus-specific inhibition of ICAM-1 gene expression by TGF-β. J Immunol 1996;157:892-900.
178. Caldenhoven E, Coffer P, Yuan J, et al: Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-γ involves binding of distinct factors to a palindromic response element. J Biol Chem 1994;269:21146-21154.
179. 3 in induction of myeloid differentiation of human leukemic cell. J Leukoc Biol 1992;51:237-243.
180. Hutchins D, Steel CM: Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int J Cancer 1994;58:80-84.
181. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994;15:321-331.
182. Hirsch MR, Wietzerbin J, Pierres M, Goridis C: Expression of Ia antigens by cultured astrocytes treated with interferon-γ. Neurosci Lett 1983;41:199-204.
183. Fontana A, Fierz W, Wekerle H: Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984;307:273-276.
184. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW: Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984;310:688-691.
185. Vidovic M, Sparacio SM, Elovitz M, Benveniste EN: Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α. J Neuroimmunol 1990;30:189-200.
186. Aloisi F, Borsellino G, Samoggia P, et al: Astrocyte cultures from human embryonic brain: Characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res 1992;32: 494-506.
187. Shrikant P, Benos DJ, Tang L-P, Benveniste EN: HIV gp120 enhances ICAM-1 gene expression in glial cells: Involvement of JAK/STAT and protein kinase C signaling pathways. J Immunol 1996; 156:1307-1314.
188. Vass K, Lassmann H: Intrathecal application of interferon gamma. Am J Pathol 1990;137:789-800.
189. Lee SC, Moore GRW, Golenwsky G, Raine CS: Multiple sclerosis: A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 1990;49:122-136.
190. Hickey WF, Osborn JP, Kirby WM: Expression of Ia molecules by astrocytes during acute experimental allergic encephalmyelitis in the Lewis rat. Cell Immunol 1985;91:528-535.
191. Matsumoto Y, Kawai K, Fujiwara M: In situ Ia expression on brain cells in the rat: Autoimmune encephalomyelitis-resistant strain (BN) and susceptible strain (Lewis) compared. Immunology 1989; 66:621-627.
192. Satoh J-I, Lee YB, Kim SU: T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res 1995;704:92-96.
193. Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SM: IFN-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 1997;158:614-621.
194. Fierz W, Endler B, Reske K, Wekerle H, Fontana A: Astrocytes as antigen presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985;134:3785-3793.
195. Frei K, Lins H, Schwerdel C, Fontana A: Antigen presentation in the central nervous system: The inhibitory effect of 1L-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994;152:2720-2728.
196. Matsumoto Y, Ohmori K, Fujiwara M: Immune regulation by brain cells in the central nervous system: Microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo mimicking conditions. Immunology 1992;76:209-216.
197. Weber F, Meinl E, Aloisi F, et al: Human astrocytes are only partially competent antigen presenting cells. Brain 1994;117:59-69.
198. Williams K Jr, Ulvestad E, Cragg L, Blain M, Antel JP: Induction of primary T cell responses by human glial cells. J Neurosci Res 1993;36:382-390.
199. Cash E, Rott O: Microglial cells qualify as the stimulators of unprimed CD4+ and CD8+ T lymphocytes in the central nervous system. Clin Exp Immunol 1994;98:313-318.
200. Sedgwick JD, Möbner R, Schwender S, ter Meulen V: Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: Astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. J Exp Med 1991;173:1235-1246.
201. Williams KC, Dooley NP, Ulvestad E, et al: Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J Neurosci 1995;15: 1869-1878.
202. Takiguchi M, Frelinger JA: Induction of antigen presentation ability in purified cultures of astroglia by interferon-γ. J Mol Cell Immunol 1986;2:269-280.
203. Wekerle H: Antigen presentation by central nervous system glia; in Ransom BR, Kettenmann H (eds): Neuroglia. London, Oxford University Press, 1995, pp 685-699.
204. Meinl E, Aloisi K, Ertl B, et al: Multiple sclerosis: Immunomodulatory effects of human astrocytes on T cells. Brain 1994;117:1323-1332.
205. Panek RB, Moses H, Ting JP-Y, Benveniste EN: Tumor necrosis factor α response elements in the HLA-DRA promoter: Identification of a tumor necrosis factor α-induced DNA-protein complex in astrocytes. Proc Natl Acad Sci USA 1992;89:11518-11522.
206. Panek RB, Lee Y-J, Lindstrom-Itoh Y, Ting JP-Y, Benveniste EN: Characterization of astrocyte nuclear proteins involved in IFN-γ and TNF-α mediated class II MHC gene expression. J Immunol 1994;153:4555-4564.
207. Panek RB, Lee Y-J, Benveniste EN: TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STAT1α or modification of IFNEX expression. J Immunol 1995;154:610-619.
208. Lee SC, Collins M, Vanguri P, Shin ML: Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol 1992;148:3391-3397.
209. Sasaki A, Levison SW, Ting JPY: Differential suppression of interferon γ-induced Ia antigen expression on cultured rat astroglia and microglia by second messengers. J Neuroimmunol 1990;29: 213-222.
210. Smith ME, McFarlin DE, Dhib Jalbut S: Differential effect of interleukin-1β on Ia expression in astrocytes and microglia. J Neuroimmunol 1993;46:97-104.
211. Tontsch U, Rott O: Cortical neurons selectively inhibit MHC class II induction in astrocytes but not in microglial cells. Inter Immunol 1993;5:249-254.
212. Heuschling P: Nitric oxide modulates γ-interferon-induced MHC class II antigen expression on rat astrocytes. J Neuroimmunol 1995;57:63-69.
213. Devajyothi C, Kalvakolanu I, Babcock GT, Vasavada HA, Howe PH, Ransohoff RM: Inhibition of interferon-γ-induced major histocompatibility complex class II gene transcription by interferon-β and type β1 transforming growth factor in human astrocytoma cells: Definition of cis-element. J Biol Chem 1993;268:18794-18800.
214. Schluesener HJ: Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-α. J Neuroimmunol 1990;27:41-47.
215. Jiang H, Milo R, Swoveland P, Johnson KP, Panitch H, Dhib-Jalbul S: Interferon β-1b reduces interferon γ-induced antigen-presenting capacity of human glial and B cells. J Neuroimmunol 1995; 61:17-25.
216. Morga E, Heuschling P: Interleukin 4 down-regulates MHC class II antigens on cultured rat astrocytes. Glia 1996;17:175-179.
217. Lee Y-J, Han Y, Lu H-T, et al: Transforming growth factor-β suppresses induction of class II MHC gene expression by inhibiting class II transactivator mRNA expression. J Immunol 1997; 158:2065-2075.
218. Lu H-T, Riley JL, Babcock GT, et al: Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J Exp Med 1995;182: 1517-1525.
219. Shin ML, Koski CL: The complement system in demyelination; in Martenson R (ed): Myelin: Biology and Chemistry. Boca Raton, CRC Press, 1992, pp 801-831.
220. Levi-Strauss M, Mallat M: Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol 1987;139:2361-2366.
221. Rus HG, Kim LM, Niculescu FI, Shin ML: Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus. J Immunol 1992;148:928-933.
222. Barnum SR, Jones JL, Benveniste EN: Interferon-gamma regulation of C3 gene expression in human astroglioma cells. J Neuroimmunol 1992;38:275-282.
223. Barnum SR, Jones JL: Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1β. Neurosci Lett 1995;197:121-124.
224. Barnum SR, Jones JL, Müller Ladner U, Samimi A, Campbell IL: Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte targeted interleukin-6 expression. Glia 1996;18:107-117.
225. Gasque P, Julen N, Ischenko AM, et al: Expression of complement components of the alternative pathway by glioma cell lines. J Immunol 1992;149:1381-1387.
226. Barnum SR, Jones JL: Transforming growth factor-β1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J Immunol 1994;152:765-773.
227. Gasque P, Fontaine M, Morgan BP: Complement expression in human brain. J Immunol 1995; 154:4726-4733.
228. Barnum SR, Ishii Y, Agrawal A, Volanakis JE: Production and interferon-γ-mediated regulation of complement C2 and factors B and D by the astroglioma cell line U105-MG. Biochem J 1992; 287:595-601.
229. Rus HG, Niculescu F, Shin ML: Sublytic complement attack induces cell cycle in oligodendrocytes. J Immunol 1996;156:4892-4900.
230. Koski CL, Estep AE, Sawant Mane S, Shin ML, Highbarger L, Hansch GM: Complement regulatory molecules on human myelin and glial cells: Differential expression affects the deposition of activated complement proteins. J Neurochem 1996;66:303-312.
231. Shirazi Y, McMorris FA, Shin ML: Arachidonic acid mobilization and phosphoinositide turnover by the terminal complement complex, C5b-9, in rat oligodendrocyte X C6 glioma cell hybrids. J Immunol 1989;142:4385-4391.
232. Gasque P, Chan P, Fontaine M, et al: Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J Immunol 1995;155:4882-4889.
233. Lacy M, Jones J, Whittemore SR, Haviland DL, Wetsel RA, Barnum SR: Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J Neuroimmunol 1995;61:71-78.
234. Benveniste EN: Cytokine expression in the nervous system; in Keane RW, Hickey WF (eds): Immunology of the Nervous System. London, Oxford University Press, 1997, pp 419-459.
235. Malipiero UV, Frei K, Fontana A: Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990;144:3816-3821.
236. Tweardy DJ, Glazer EW, Mott PL, Anderson K: Modulation by tumor necrosis factor-α of human astroglial cell production of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony stimulating factor (G-CSF). J Neuroimmunol 1991;32:269-278.
237. Norris JG, Tang L-P, Sparacio SM, Benveniste EN: Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J Immunol 1994;152:841-850.
238. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM: Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 1990;30:201-212.
239. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A: On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 1989;19:689-694.
240. Hayashi M, Luo Y, Laning J, Stricter RM, Dorf ME: Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 1995;60: 143-150.
241. Hurwitz AA, Lyman WD, Berman JW: Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattactant protein-1. J Neuroimmunol 1995; 57:193-198.
242. Barnes DA, Huston M, Holmes R, et al: Induction of RANTES expression by astrocytes and astrocytoma cell lines. J Neuroimmunol 1996;71:207-214.
243. Fuentes ME, Durham SK, Swerdel MR, et al: Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995;155:5769-5776.
244. Benveniste EN, Kwon JB, Chung WJ, Sampson J, Pandya K, Tang L-P: Differential modulation of astrocyte cytokine gene expression by TGF-β. J Immunol 1994;153:5210-5221.
245. Kwon J, Lee SJ, Benveniste EN: A 3′ cis-acting element is involved in tumor necrosis factor-α gene expression in astrocytes. J Biol Chem 1996;271:22383-22390.
246. Benveniste EN, Tang LP, Law RM: Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and IL-10. Int J Dev Neurosci 1995;13:341-349.
247. da Cunha A, Vitkovic L: Transforming growth factor-beta (TGF-β1) expression and regulation in rat cortical astrocytes. J Neuroimmunol 1992;36:157-169.
248. Aloisi F, Care A, Borsellino G, et al: Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 1992;149:2358-2366.
249. Lee SC, Liu W, Roth P, Dickson DW, Berman JW,Brosnan CF: Macrophage colony-stimulating factor in human fetal astrocytes and microglia: Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. J Immunol 1993;150:594-604.
250. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW: Cytokine production by human fetal microglia and astrocytes: Differential induction by lipopolysaccharide and IL-1β. J Immunol 1993; 150:2659-2667.
251. Golde DW, Gasson JC: Hormones that stimulate the growth of blood cells. Scient Am 1988;July:62-70.
252. Giulian D, Ingeman JE: Colony stimulating factors as promoters of ameboid microglia. J Neurosci 1988;8:4707-4717.
253. Maysinger D, Berezovskaya O, Fedoroff S: The hematopoietic cytokine colony stimulating factor 1 is also a growth factor in the CNS. II. Microencapsulated CSF-1 and LM-10 cells as delivery systems. Exp Neurol 1996;141:47-56.
254. Appel K, Honegger P, Gebicke-Haerter PJ: Expression of interleukin-3 and tumor necrosis factor-β mRNAs in cultured microglia. J Neuroimmunol 1995;60:83-91.
255. Gebicke-Haerter PJ, Appel K, Taylor GD, et al: Rat microglial interleukin-3. J Neuroimmunol 1994;50:203-214.
256. Appel K, Buttini M, Sauter A, Gebicke-Haerter PJ: Cloning of rat interleukin-3 receptor β-subunit from cultured microglia and its mRNA expression in vivo. J Neurosci 1995;15:5800-5809.
257. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL: Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 1996;97:1512-1524.
258. Ohno K, Suzumura A, Sawada M, Marunouchi T: Production of granulocyte/macrophage colony-stimulating factor by cultured astrocytes. Biochem Biophys Res Commun 1990;169:719-724.
259. Hao C, Guilbert LJ, Fedoroff S: Production of colony-stimulating factor-1 (CSF-1) by mouse astroglia in vitro. J Neurosci Res 1990;27:314-323.
260. Thery C, Hetier E, Evrard C, Mallat M: Expression of macrophage colony-stimulating factor gene in the mouse brain during development. J Neurosci Res 1990;26:129-133.
261. Sobel RA, Mitchell ME, Fondren G: Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-1316.
262. Cannella B, Cross AH, Raine CS: Adhesion-related molecules in the central nervous system: Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab Invest 1991;65:23-31.
263. O'Neill JK, Butter C, Baker D, et al: Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology 1991;72:520-525.
264. Bö L, Peterson JW, Mork S, et al: Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 1996;55: 1060-1072.
265. Lee TT, Martin FC, Merrill JE: Lymphokine induction of rat microglia multinucleated giant cell formation. Glia 1993;8:51-61.
266. Satoh S, Nüssler AK, Liu Z-Z, Thomson AW: Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes. Immunology 1994;82:571-576.
267. Look DC, Rapp SR, Keller BT, Holtzman MJ: Selective induction of intercellular adhesion molecule-1 by interferon-γ in human airway epithelial cells. Am J Physiol 1992;263:L79-L87.
268. Möst J, Schwaeble W, Drach J, Sommerauer A, Dierich MP: Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines. J Immunol 1992;148:1635-1642.
269. Steiniger B, Falk P, Van der Meide PH: Interferon-γ in vivo. Induction and loss of class II MHC antigens and immature myelomonocytic cells in rat organs. Eur J Immunol 1988;18:661-669.
270. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer E: Microglia in degenerative neurological disease. Glia 1993;7:84-92.
271. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7:75-83.
272. Wingren AG, Parra E, Varga M, et al: T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 1995;15:235-253.
273. Woodroofe MN, Hayes GM, Cuzner ML: Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma treated microglia isolated from adult rat brain. Immunology 1989;68:421-426.
274. Cash E, Zhang Y, Rott O: Microglia present myelin antigens to T cells after phagocytosis of oligodendrocytes. Cell Immunol 1993;147:129-138.
275. Walker WS, Gatewood J, Olivas E, Askew D, Havenith CEG: Mouse microglial cell lines differing in constitutive and interferon-γ-inducible antigen presenting activities for naive and memory CD4+ and CD8+ T cells. J Neuroimmunol 1995;63:163-174.
276. Dhib-Jalbut S, Gogate N, Jiang H, Eisenberg H, Bergey G: Human microglia activate lymphoproliferative responses to recall viral antigens. J Neuroimmunol 1996;65:67-73.
277. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD: Normal adult ramified microglia separated from other cental nervous system macrophages by flow cytometric sorting. J Immunol 1995;154: 4309-4321.
278. Kuchroo VK, Das MP, Brown JA, et al: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80: 707-718.
279. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD: Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 1996;184:1737-1745.
280. Mizuno T, Sawada M, Marunouchi T, Suzumura A: Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994;205:1907-1915.
281. Hayashi M, Dorf ME, Abromson Leeman S: Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J Neuroimmunol 1993;48:23-32.
282. Loughlin AJ, Woodroofe MN, Cuzner ML: Modulation of interferon-γ-induced major histocompatibility complex class Il and Fc receptor expression on isolated microglia by transforming growth factor-β1, interleukin-4, noradrenaline and glucocorticoids. Immunology 1993;79:125-130.
283. Suzumura A, Sawada M, Itoh Y, Marunouchi T: Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol 1994;53:209-218.
284. Briers TW, Desmaretz C, Vanmechelen E: Generation and characterization of mouse microglial cell lines. J Neuroimmunol 1994;52:153-164.
285. Murphy GM, Jr., Jia X-C, Song Y, et al: Macrophage inflammatory protein 1-α mRNA expression in an immortalized microglial cell line and cortical astrocyte cultures. J Neurosci Res 1995;40: 755-763.
286. Giulian D, Baker TJ, Shih LC, Lachman LB: Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986;164:594-604.
287. Righi M, Mori L, De Libero G, et al: Monokine production by microglial cell clones. Eur J Immunol 1989;19:1443-1448.
288. Gottschall PE, Yu X, Bing B: Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J Neurosci Res 1995;42:335-342.
289. Chao CC, Hu S, Sheng WS, Peterson PK: Tumor necrosis factor-alpha production by human fetal microglial cells: Regulation by other cytokines. Dev Neurosci 1995;17:97-105.
290. Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK: Tumor necrosis factor-α mediates the release of bioactive transforming growth factor-β in murine microglial cell cultures. Clin Immunol Immunopathol 1995;77:358-365.
291. Norris JG, Benveniste EN: Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993;45:137-146.
292. Becher B, Dodelet V, Fedorowicz V, Antel JP: Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 1996; 98:1539-1543.
293. Lodge PA, Sriram S: Regulation of microglial activation by TGF-β, IL-10, and CSF-1. J Leukoc Biol 1996;60:502-508.
294. Clavo CF, Yoshimura T, Gelman M, Mallat M: Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur J Neurosci 1996;8:1725-1734.
295. Lafortune L, Nalbantoglu J, Antel JP: Expression of tumor necrosis factor α (TNFα) and interleukin 6 (IL-6) mRNA in adult human astrocytes: Comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol 1996;55:515-521.
296. Meda L, Bernasconi S, Bonaiuto C, et al: β-amyloid (25-35) peptide and IFN-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J Immunol 1996;157:1213-1218.
297. Meda L, Bonaiuto C, Szendrei GI, Ceska M, Rossi F, Cassatella MA: β-Amyloid (25-35) induces the production of interleukin-8 from human monocytes. J Neuroimmunol 1995;59:29-33.
298. Meda L, Cassatella MA, Szendrel GI, et al: Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995;374:647-650.
299. Fisher SN, Vanguri P, Shin HS, Shin ML: Regulatory mechanisms of murantes and CRG-2 chemokine gene induction in central nervous system glial cells by virus. Brain Behavior Immun 1995;9: 331-344.
300. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP: IL-10 production by adult human derived microglial cells. Neurochem Int 1996;29:55-64.
301. Suzumura A, Sawada M, Marunouchi T: Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor. Brain Res 1996;713:192-198.
302. Sebire G, Delfraissy J, Demotes-Mainard J, Oteifeh A, Emilie D, Tardieu M: Interleukin-13 and interleukin-4 act as interleukin-6 inducers in human microglial cells. Cytokine 1996;8:636-641.
303. Zajicek JP, Wing M, Scolding NJ, Compston DAS: Interactions between oligodendrocytes and microglia. Brain 1992;115:1611-1631.
304. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 1995;13:251-276.
305. Benveniste EN, Merrill JE: Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 1986;321:610-613.
306. Benveniste EN, Herman PK, Whitaker JN: Myelin basic protein-specific RNA levels in interleukin-2-stimulated oligodendrocytes. J Neurochem 1987;49:1274-1279.
307. Benveniste EN, Tozawa H, Gasson JC, Quan S, Golde DW, Merrill JE: Response of human glioblastoma cells to recombinant interleukin-2. J Neuroimmunol 1988;17:301-314.
308. Okamoto Y, Minamoto S, Shimizu K, Mogami H, Taniguchi T: Interleukin 2 receptor β chain expressed in an oligodendroglioma line binds interleukin 2 and delivers growth signal. Proc Natl Acad Sci USA 1990;87:6584-6588.
309. Eitan S, Zisling R, Cohen A, et al: Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration. Proc Natl Acad Sci USA 1992;89:5442-5446.
310. Eitan S, Schwartz M: A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 1993;261:106-108.
311. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE: Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-2141.
312. Paul NL, Ruddle NH: Lymphotoxin. Annu Rev Immunol 1988;6:407-138.
313. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF: Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J Immunol 1991;147:1522-1529.
314. Wilt SG, Milward E, Zhou JM, et al: In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann Neurol 1995;37:381-394.
315. Tchélingérian J-L, Monge M, Le Saux F, Zalc B, Jacque C: Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Neurochem 1995;65:2377-2380.
316. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G: Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 1995;92:11294-11298.
317. Akassoglou K, Probert L, Kontogeorgos G, Kollias G: Astrocyte-specific but not neuron specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997;158:438-445.
318. Mayer M, Bhakoo K, Noble M: Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994;120:143-153.
319. Louis J-C, Magal E, Takayama S, Varon S: CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993;259:689-692.
320. D'Souza SD, Alinauskas KA, Antel JP: Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 1996;43:289-298.
321. D'Souza S, Alinauskas K, McCrea E, Goodyer C, Antel JP: Differential susceptibility of human CNS-derived cell populations to TNF dependent and independent immune-mediated injury. J Neurosci 1995;15:7293-7300.
322. Saad B, Constam DB, Ortmann R, Moos M, Fontana A, Schachner M: Astrocyte-derived TGF-β2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes. J Cell Biol 1991;115:473-484.
323. Awatsuji H, Furukawa Y, Hirota M, et al: Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J Neurosci Res 1993;34:539-545.
324. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV: Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996;383:716-719.
325. Turnley AM, Miller JFAP, Bartlett PF: Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neurosci Lett 1991;123:45-48.
326. Suzumura A, Silberberg DH, Lisak RP: The expression of MHC antigens on oligodendrocytes: Induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 1986;11:179-190.
327. Turnley AM, Morahan G, Okano H, et al: Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 1991;353:566-569.
328. Power C, Kong P-A, Trapp BD: Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J Neurosci Res 1996;44:165-173.
329. Merrill JE, Matsushima K: Production of and response to interleukin-1 by cloned human oligodendroglioma cell lines. J Biol Regul Homeost Agents 1988;2:77-86.
330. de Cunha A, Jefferson JA, Jackson RW, Vitkovic L: Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J Neuroimmunol 1993;42:71-86.